Abstract
Context
Magnesium sulphate is now the gold standard for the control of eclamptic fits. The place of low-dose magnesium sulphate for the control of eclamptic seizures is yet to be determined.
Objectives
To determine the effectiveness of low-dose magnesium sulphate in controlling eclamptic fits.
Study design
Randomized controlled trial comparing low-dose with standardized dosing regimen.
Setting
Labour Unit of the department of Obstetrics and Gynecology Federal Medical Centre Azare, north-eastern Nigeria.
Protocol
Thirty-nine patients randomized into the low-dose regimen group received 9 g loading dose (4 g iv and 5 g im) and im maintenance of 2.5 g four hourly for 24 h post-delivery or post last fit, while the 33 patients in the standard dose regimen group received loading dose of 14 g followed by im maintenance dose of 5 g four hourly. In both study groups, 2 g iv of magnesium sulphate is given for breakthrough fits and 10 ml of 10 % calcium gluconate (slowly iv) was administered in the event of toxicity. Outcome measures include recurrent fits, mode of delivery, mean Apgar Score at 5 min, perinatal death, maternal complications including death.
Result
The mean age of the 72 patients was 22.3 ± 5.4 years and 60 % were primigravidas. Intrapartum eclampsia was encountered in 44 % of the patients followed by antepartum eclampsia (26 %). Overall 4.2 % recurrent convulsion rate was documented and it is not different among the study groups. There were also no differences in both foetal and maternal outcomes in the two study groups.
Conclusion
The effectiveness of low-dose regimen of magnesium sulphate appeared comparable to the ‘standard dose regimen’. Low-dose regimen may guarantee more safety and in an environment (such as ours) where cost is an important determinant of accessibility to qualitative health services, it is certainly attractive. More studies are needed to establish the place of low-dose regimen of magnesium sulphate in the management of eclampsia.
References
World Health Organization (2006) Managing eclampsia. Geneva, pp 24–27
Chappell L (2004) Recent advances in pre-eclampsia and eclampsia. Trop Doc 34:1–2
Ransmars C, Graham W (2006) Maternal mortality: who, when, where and why? Lancet 368:1189–1200
Ade-Ojo IP, Loto OM (2008) Outcome of eclampsia at the Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife. Niger J Clin Pract 11(3):279–284
Tukur J, Umar BA, Rabiu A (2007) Pattern of eclampsia in a tertiary health facility situated in a semi-rural town in Northern Nigeria. Ann Afr Med 6(4):164–167
Efetie ER, Okafor UV (2007) Maternal outcome in eclamptic patients in Abuja, Nigeria—a 5 year review. Niger J Clin Pract 10(4):309–313
Ekele BA, Bello SO, Adamu AN (2007) Clusters of eclampsia in a Nigerian teaching hospital. Int J Gynaecol Obstet 96(1):62–66
Onakewhor JU, Gharoro EP (2008) Changing trends in maternal mortality in a developing country. Niger J Clin Pract 11(2):111–120
Aboyeji AP, Ijaya MA, Fawole AA (2007) Maternal mortality in a Nigerian teaching hospital—a continuing tragedy. Trop Doc 37(2):83–85
Ujah IA, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE (2005) Factors contributing to maternal mortality in north-central Nigeria: a seventeen-year review. Afr J Reprod Health 9(3):27–40
Duley L, Gulmezoglu AM, Henderson-Smart DJ (2003) Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2:CD 000025
Ekele B (2006) Magnesium sulphate: the gold standard for the treatment of eclampsia and pre-eclampsia. Trop J Obstet Gynaecol 23(1):1–2
Campbell OMR, Graham W (2006) Strategies for reducing maternal mortality: getting on with what works. The Lancet Maternal Survival Series, pp 1–16. doi:10.1016/S0140-6736(06)69381-1
Ekele BA, Ahmad Y (2004) Magnesium sulphate regimens for eclampsia. Int J Gynaecol Obstet 87:149–150
Miller D (2007) Hypertension in pregnancy. In: Decherney AH, Nathan L, Goodwin M, Laufer N (eds) Current diagnosis and treatment obstetrics and gynecology. McGraw-Hill, New York, pp 321–327
Mahajan NN, Thomas A, Soni RN, Gaikwad NL, Jain SM (2009) ‘Padhar regimen—a low dose magnesium sulphate treatment for eclampsia. Gyecol Obstet Investig 67(1):20–24
Olatunji AO, Sule-Odu AO (2007) Presentation and outcome of eclampsia at a Nigerian university hospital. Niger J Clin Pract 10(1):1–4
Chisara CU, Paul AF, Robert CW (2006) Treatment of eclampsia with magnesium sulphate in Aba, south-eastern Nigeria. Trop J Obstet Gynaecol 23(1):20–22
Egberase GO, Ebeigbe PN (2006) Eclampsia: ten-years of experience in a rural tertiary hospital in the Niger delta, Nigeria. J Obstet Gynaecol 26(5):414–417
Sardesai S, Ayachit S (2007) Eclampsia management—what is new? In: Shah MR (ed) Hypertensive disorders of pregnancy. Jaypee, New Delhi, pp 263–277
Adewale IF, Oladokun A, Okewole AL, Omigbodun AO, Afolabi A, Ekele B, Audu LR, Obed Y (2000) Magnesium sulphate for treatment of eclampsia: the Nigerian experience. Afr J Med Med Sci 29(3–4):239–241
The Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclamptic trial. Lancet 345:1455–1463
Begum R, Begum A, Johanson R, Ali MN, Akhter S (2001) A low dose (“Dhaka”) magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand 80(11):998–1002
Chowdhury JR, Chaudhuri S, Bhattacharyya N, Biswas Pk, Panpalia M (2009) Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia. J Obstet Gynaecol Res 35(1):119–125
Ekele BA, Muhammed D, Bello LN, Namadina IM (2009) Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen. BMC Res Notes 19(2):165
Conflict of interest
We declare that there is no conflict of interest in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdul, M.A., Nasir, U.I., Khan, N. et al. Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial. Arch Gynecol Obstet 287, 43–46 (2013). https://doi.org/10.1007/s00404-012-2523-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2523-z